- জেনেরিক নাম
- Ferric Carboxymaltose
- শক্তি
- 750 mg/15 ml
- ডোজ ফর্ম
- Injection
- প্রস্তুতকারক
- Advanced Chemical Industries PLC
Ferox 15 ml IV Injection/Infus Injection
Ferox 15 ml IV Injection/Infus 750 mg/15 ml সম্পর্কে
Ferox 15 ml IV Injection/Infus 750 mg/15 ml একটি ইনজেকশন ঔষধ, যার জেনেরিক নাম Ferric Carboxymaltose এবং শক্তি ৭৫০ mg/১৫ ml। এই ব্র্যান্ডের প্রস্তুতকারক Advanced Chemical Industries PLC। Ferric Carboxymaltose-এর অন্য ব্র্যান্ডগুলো এই পাতায় কম দাম থেকে সাজানো আছে, দাম তুলনা করতে পারবেন। ডাক্তারের প্রেসক্রিপশন মেনে চলুন এবং অন্য ব্র্যান্ড খাওয়া যাবে কি না তা ফার্মাসিস্টের কাছ থেকে জেনে নিন।
Ferric Carboxymaltose-এর ১৫টি ব্র্যান্ড বাংলাদেশে তালিকাভুক্ত। সবচেয়ে কম দাম Ferium Injection 500 mg/10 ml-এর, প্রতি ইউনিট ৳ ৭০০।
Ferox 15 ml IV Injection/Infus 750 mg/15 ml কী?
Ferox 15 ml IV Injection/Infus is a parenteral iron preparation. It is used in adults with iron deficiency anemia who cannot tolerate oral iron or who have not responded well to it, and in adults with non-dialysis dependent chronic kidney disease. The active ingredient is ferric carboxymaltose, a complex of iron hydroxide and a carbohydrate polymer that releases iron to help replace body iron stores. It is given by a healthcare professional as an injection or infusion. The doctor decides the dose and course based on the patient's weight and needs.
Ferox 15 ml IV Injection/Infus-এর ব্যবহার
Ferox 15 ml IV Injection/Infus is used to treat iron deficiency anemia in adults who have intolerance to oral iron or have had an unsatisfactory response to oral iron. It is also used in adults with non-dialysis dependent chronic kidney disease. It is a parenteral iron preparation, meaning the iron is given directly into the body rather than by mouth.
Ferox 15 ml IV Injection/Infus কীভাবে ব্যবহার করবেন
Ferox 15 ml IV Injection/Infus is given by a healthcare professional as an intravenous injection or infusion. The doctor decides the dose, the number of doses, and the interval between them, taking into account the patient's weight and condition. Do not attempt to administer it yourself. Tell the doctor about any previous reactions to iron preparations before receiving it.
Ferox 15 ml IV Injection/Infus-এর পার্শ্বপ্রতিক্রিয়া
Side effects of Ferox 15 ml IV Injection/Infus may include nausea, vomiting, dizziness, headache, flushing, hypertension or hypotension, constipation, altered taste, itching, rash, hives, wheezing, injection site discoloration, and increased liver enzymes. Serious allergic-type reactions, including anaphylactic reactions, have been reported. The doctor monitors for such reactions during and after administration. Seek immediate medical attention if you feel unwell during or after the injection.
সতর্কতা ও নিরাপত্তা
Ferox 15 ml IV Injection/Infus should only be given where staff and equipment for treating allergic reactions are immediately available. Tell your doctor if you have had any reaction to iron preparations or are allergic to any ingredient. It is not known if it is safe in pregnancy; pregnancy category C means animal studies showed harm to the fetus but human studies are lacking. The doctor will decide if the potential benefit justifies the risk. Breastfeeding mothers, people with other medical conditions, and those taking other medicines should ask the doctor first.
সাধারণ প্রশ্ন
How is Ferox 15 ml IV Injection/Infus given?
It is given by a healthcare professional as an intravenous injection or infusion. The doctor decides the dose, the number of doses, and the schedule based on your weight and condition. Do not try to use it yourself at home.
What is Ferox 15 ml IV Injection/Infus used for and what kind of medicine is it?
It is used for iron deficiency anemia in adults who cannot tolerate or do not respond to oral iron, and in some adults with chronic kidney disease. It is a parenteral iron preparation, so the iron is given directly into the body.
What does the generic name ferric carboxymaltose mean?
Ferric carboxymaltose is a complex of iron (ferric) hydroxide and a carbohydrate polymer called carboxymaltose. This complex is designed to release iron slowly after it is given into the body, helping to replace iron stores.
Who should ask a doctor before receiving Ferox 15 ml IV Injection/Infus?
Anyone with a known allergy to iron preparations or any ingredient should tell the doctor. Pregnant or breastfeeding women, and people with other medical conditions or on other medicines, should ask the doctor first. Only a healthcare professional can decide if it is suitable.
নির্দেশনা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Ferric Carboxymaltose is indicated for the treatment of iron deficiency anemia in adult patients-- Who have intolerance to oral iron or have had unsatisfactory response to oral iron
- Who have non-dialysis dependent chronic kidney disease.
ফার্মাকোলজি
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Non-dextran, IV is a colloidal iron hydroxide in complex with carboxymaltose, a carbohydrate polymer that releases iron; replaces iron stores found in hemoglobin, myoglobin, and enzymes; works to transport oxygen via hemoglobin Macrophage engulf FCM from blood and control iron release. Transferrin saturates and, Iron into the liver, spleen and Bone marrow.মাত্রা ও সেবনবিধি
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
For patients weighing 50 kg or more: Give Ferric Carboxymaltose in two doses separated by at least 7 days. Give each dose as 750 mg for a total cumulative dose not to exceed 1500 mg of iron per course.For patients weighing less than 50 kg: Give Ferric Carboxymaltose in two doses separated by at least 7 days. Give each dose as 15 mg/kg body weight for a total cumulative dose not to exceed 1500 mg of iron per course.
The dosage of Ferric Carboxymaltose is expressed in mg of elemental iron. Each mL of Ferric Carboxymaltose contains 50 mg of elemental iron. Ferric Carboxymaltose treatment may be repeated if iron deficiency anemia reoccurs.
Administer Ferric Carboxymaltose intravenously, either as an undiluted slow intravenous push or by infusion. When administering as a slow intravenous push, give at the rate of approximately 100 mg (2 mL) per minute. When administered via infusion, dilute up to 750 mg of iron in no more than 250 mL of sterile 0.9% sodium chloride injection, USP, such that the concentration of the infusion is not less than 2 mg of iron per mL and administer over at least 15 minutes.
When added to an infusion bag containing 0.9% Sodium Chloride Injection, USP, at concentrations ranging from 2 mg to 4 mg of iron per mL, Ferric Carboxymaltose solution is physically and chemically stable for 72 hours when stored at room temperature. To maintain stability, do not dilute to concentrations less than 2 mg iron/mL.
Inspect parenteral drug products visually for the absence of particulate matter and discoloration prior to administration. The product contains no preservatives. Each vial of Ferric Carboxymaltose is intended for single use only. Any unused drug remaining after injection must be discarded.
Avoid extravasation of Ferric Carboxymaltose since brown discoloration of the extravasation site may be long lasting. Monitor for extravasation. If extravasation occurs, discontinue the Ferric Carboxymaltose administration at that site.
ঔষধের মিথষ্ক্রিয়া
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
There are no known drug interactions and none well documented.প্রতিনির্দেশনা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Hypersensitivity to any of its components.পার্শ্ব প্রতিক্রিয়া
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Nausea, Hypertension, Flushing, Decreased blood phosphorus, Dizziness, Vomiting, Pruritus, Rash, Urticaria, Wheezing, Injection site discoloration, Headache, Increased alanine aminotransferase), Dysgeusia, Hypotension, Constipation, Serious anaphylactic/anaphylactoid reactionsগর্ভাবস্থায় ও স্তন্যদানকালে
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Pregnancy Category C. Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risksসতর্কতা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Hypersensitivity Reactions: Serious hypersensitivity reactions, including anaphylactic-type reactions, some of which have been life-threatening and fatal, have been reported in patients receiving Ferric carboxymaltose. Patients may present with shock, clinically significant hypotension, loss of consciousness, and/or collapse. Monitor patients for signs and symptoms of hypersensitivity during and after Ferric carboxymaltose administration for at least 30 minutes and until clinically stable following completion of the infusion. Only administer Ferric carboxymaltose when personnel and therapies are immediately available for the treatment of serious hypersensitivity reactions. Other serious or severe adverse reactions potentially associated with hypersensitivity which included, but not limited to, pruritus, rash, urticaria, wheezing, or hypotension may occur.Hypertension: Transient elevations in systolic blood pressure, sometimes occurring with facial flushing, dizziness, or nausea were observed. These elevations generally occurred immediately after dosing and resolved within 30 minutes. Monitor patients for signs and symptoms of hypertension following each Ferric carboxymaltose administration.
সংরক্ষণ
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Do not store above 30°C. Do not freeze.বিকল্প ব্র্যান্ড: Ferric Carboxymaltose
একই জেনেরিকের অন্য ব্র্যান্ড, কম দাম আগে।
Jectofer Injection Injection
500 mg/10 ml
Globe Pharmaceuticals Ltd.
৳ ৬৮৬ ৳ ৭০০ ২% ছাড় প্রতি ইউনিট
Ferox 20 ml IV Injection/Infus Injection
1000 mg/20 ml
Advanced Chemical Industries PLC
দাম দেওয়া নেই
ঔষধের তথ্য শুধু জানার জন্য, এটি চিকিৎসা পরামর্শ নয়। সবসময় ডাক্তারের প্রেসক্রিপশন মানুন এবং ফার্মাসিস্টের সাথে কথা বলুন।